- Home
- NGS vs CADL Comparison
NGS vs CADL Comparison
Compare NGS & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGS | CADL |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.9M | 339.8M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NGS | CADL |
|---|---|---|
| Price | $32.38 | $5.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $35.67 | $19.43 |
| AVG Volume (30 Days) | 93.7K | ★ 990.7K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | ★ 14.85 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $166,824,000.00 | N/A |
| Revenue This Year | $9.50 | N/A |
| Revenue Next Year | $13.88 | N/A |
| P/E Ratio | $21.60 | ★ N/A |
| Revenue Growth | ★ 9.53 | N/A |
| 52 Week Low | $16.73 | $4.25 |
| 52 Week High | $33.82 | $13.68 |
Technical Indicators
Market Signals| Indicator | NGS | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 53.98 |
| Support Level | $31.51 | $5.48 |
| Resistance Level | $33.15 | $5.98 |
| Average True Range (ATR) | 1.07 | 0.42 |
| MACD | -0.17 | 0.03 |
| Stochastic Oscillator | 54.27 | 48.06 |
Price Performance
Historical ComparisonAbout NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.